Presentation
Prostate cancer high risk patient. Staging prior to radical treatment.
Patient Data







There is marked focal PSMA uptake in the right side of the prostate corresponding to the primary tumor. There is a 10 mm mildly PSMA avid right pelvic sidewall lymph node which is likely involved. No nodal or metastatic disease elsewhere.
Case Discussion
F-18 PSMA is useful in the staging of high risk prostate cancer patients being considered for radical therapy.
F-18 PSMA has been shown to have a higher diagnostic accuracy for primary staging compared with CT and bone scan (92% vs 65% respectively), a greater treatment impact (28% vs 15% respectively) and fewer uncertain results (7% vs 23% respectively) 1.